Skip to Content

Tag: richard admani


Prodigy responds to FDA warning

September 5, 2013HME News Staff

CHARLOTTE, N.C. - Prodigy Diabetes Care has conducted a regulatory assessment by an independent auditor to examine, review and revise certain procedures and training to ensure compliance with FDA requirements, it told patients, caregivers and partners in a Sept. 4 letter.“Prodigy assures you that this attention to improvement is an ongoing effort to ensure full compliance,” stated CEO Richard Admani in the letter.In a Feb. 22 letter, the FDA warned Prodigy about numerous violations, including...

Blood Glucose Monitors, FDA, Prodigy Diabetes Care, richard admani

Read Full Articlered right arrow icon